Alyeska Investment Group
CELL

Alyeska Investment Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Alyeska Investment Group’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-75,000
Closed -$3.36M – 836
2021
Q2 		$3.36M Buy
75,000
+55,000
+275% +$2.55M 0.04% 424
2021
Q1 		$1M Buy
+20,000
New +$1.36M 0.01% 559
2020
Q4 		– Sell
-30,000
Closed -$2.29M – 632
2020
Q3 		$2.29M Buy
+30,000
New +$1.91M 0.03% 337

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Alyeska Investment Group's CELL Position: Q3 2021 in Review

Alyeska Investment Group sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2021, closing a stake of 75,000 shares — an estimated $3.36M sold.

Alyeska Investment Group first reported a position in CELL in Q3 2020 and held it in 3 quarters. The position peaked at $3.36M in Q2 2021. 137 funds tracked by Wall St. Rank hold CELL as of Q3 2021.

  • Alyeska Investment Group reported no remaining PhenomeX Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 75,000 PhenomeX Inc. Common Stock shares in Q3 2021, an estimated $3.36M.
  • Alyeska Investment Group first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Alyeska Investment Group's PhenomeX Inc. Common Stock position peaked at $3.36M in Q2 2021.
  • 137 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2021.

Based on Alyeska Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.